NCT04748289

Brief Summary

In neurocritical care, besides the standard intensive care monitoring, even more data are obtained from the very complex pathophysiological changes in brain disease. Medical staff for decision-making cannot integrate the huge amount of clinical data generated every second and visualized on different monitors, anymore. Lack of data integration and usability is a major reason that only few of the knowledge physicians use in this field is evidence based. Early warning systems, powered by predictive algorithms that detect critical states before they happen would allow the staff to intervene early and mitigate or even prevent such a critical state.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 27, 2021

Completed
14 days until next milestone

First Posted

Study publicly available on registry

February 10, 2021

Completed
19 days until next milestone

Study Start

First participant enrolled

March 1, 2021

Completed
5.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 9, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 9, 2026

Completed
Last Updated

May 4, 2026

Status Verified

April 1, 2026

Enrollment Period

5.1 years

First QC Date

January 27, 2021

Last Update Submit

April 27, 2026

Conditions

Keywords

Secondary brain injuriesCOVID-19Subarachnoid hemorrhage

Outcome Measures

Primary Outcomes (5)

  • Verification of ICU Cockpit software for remote monitoring of isolated patients

    Repeatability, reliability, performance of prediction of models results will be testet against ground truth (annotations by experts).

    2 years

  • Verification of ICU Cockpit software ICU Cockpit Stable State

    Repeatability, reliability, performance of prediction of models results will be testet against ground truth (annotations by experts).

    2 years

  • Verification of ICU Cockpit software Cerebral Ischemia

    Prediction score estimated by the app ICU Cockpit Cerebral Ischemia compared to probability estimation by medical experts in surveys.

    2 years

  • Adverse events, complaints and use-errors reporting

    Reporting of adverse events (incl. device deficiencies), complaints as well as use-errors.

    2 years

  • Usability testing

    Usability testing by distributing the Software Usability Questionnaire to involved medical staff (n=65).

    2 years

Study Arms (1)

NICU patients

EXPERIMENTAL

All patients admitted to the Neurointensive Care Unit (NICU)

Device: ICU Cockpit software testing

Interventions

the ICU Cockpit Software Platform is intended to be used for monitoring of patient characteristics and vital physiological parameters in patients at the Neurointensive Care Unit of the University Hospital Zurich. Furthermore, three different applications for prognostication and prediction of complications will be tested: 1. ICU Cockpit COVID-19 for remote monitoring of isolated patients, 2. ICU Cockpit Stable State for a comprehensive visualization of vital parameters and as additional aid in early detection of imminent critical complications 3. ICU Cockpit Cerebral Ischemia for the prediction of delayed DCI in patients with subarachnoid hemorrhage (SAH).

NICU patients

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • All patients admitted to the Neurointensive Care Unit (NICU)
  • Informed Consent by signature from representative / patient

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Zurich

Zurich, Canton of Zurich, CH-8091, Switzerland

Location

Related Publications (4)

  • Callaway E, Cyranoski D, Mallapaty S, Stoye E, Tollefson J. The coronavirus pandemic in five powerful charts. Nature. 2020 Mar;579(7800):482-483. doi: 10.1038/d41586-020-00758-2. No abstract available.

    PMID: 32203366BACKGROUND
  • Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y, Pan S, Zou X, Yuan S, Shang Y. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.

    PMID: 32105632BACKGROUND
  • Hollander JE, Carr BG. Virtually Perfect? Telemedicine for Covid-19. N Engl J Med. 2020 Apr 30;382(18):1679-1681. doi: 10.1056/NEJMp2003539. Epub 2020 Mar 11. No abstract available.

    PMID: 32160451BACKGROUND
  • Vergouwen MD, Ilodigwe D, Macdonald RL. Cerebral infarction after subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and -independent effects. Stroke. 2011 Apr;42(4):924-9. doi: 10.1161/STROKEAHA.110.597914. Epub 2011 Feb 10.

    PMID: 21311062BACKGROUND

MeSH Terms

Conditions

COVID-19Subarachnoid Hemorrhage

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesIntracranial HemorrhagesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Emanuela Keller, MD

    University of Zurich

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: Open labelled, single centre clinical investigation, with the new ICU Cockpit Software Platform (medical device).
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Neurocritical Care Unit, University Hospital Zurich

Study Record Dates

First Submitted

January 27, 2021

First Posted

February 10, 2021

Study Start

March 1, 2021

Primary Completion

April 9, 2026

Study Completion

April 9, 2026

Last Updated

May 4, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations